Dear Dr letter just after the Vioxxwithdrawal. “The cardiovascular safety profile of Celebrex has been extensively studied. The data do not indicate significant ... [more...]
Cascade system in place and working e.g. Vioxxwithdrawal; Adequate resources - Funding secured through LDP for Elderly care pharmacist to review medicines at Nursing and ... [more...]
Like it or not, the Vioxxwithdrawal and other drug safety concerns have heightened the public's concern about FDA's performance. In order for the FDA to continue as the "gold ... [more...]
Recent Actions in Response to Drug Safety Problems Since Vioxxwithdrawal Rejected a slew of experimental drugs or delayed their approval and required more data. [more...]
... 16.1.3 Post-marketing Reports for Bextra 16.1.4 Withdrawal of Bextra 16.2 TheFallof Vioxx 16.2.1 Public Health Advisory 16.2.2 Repercussions from the VioxxWithdrawal 16.2.3 Fearof COX ... [more...]
The recent Vioxxwithdrawal and increased scrutiny on other COX-2 inhibitors has created a significant market opportunity for Pennsaid. Solvay has developed a comprehensive ... [more...]
... for clarification if "one of the perceptions was it was no longer possible to continue the trial" because "of a very large number of dropouts from the trial after the Vioxxwithdrawal". [more...]
Following the publicity surrounding the rofecoxib (Vioxx) withdrawal, however, the FDA may be forced into action. In late April, Congress introduced legislation to establish the Center ... [more...]
... report "The Future of Drug Safety," added significant weight to the call for changes to the drug safety system. 4 The report, commissioned by the FDA in the wake of the Vioxxwithdrawal ... [more...]
... use an analysis of internal rate of return, along with the information obtained from the Fosamax patent loss, to estimate the loss in expected profits due to the Vioxxwithdrawal. [more...]
The Harris Poll ® PEOPLE HEALTH CARE RESEARCH Nearly half (48%) of U.S. adults and more than three quarters (78%) of Vioxxusers 1 report closely following the news coverage about the ... [more...]
... SECTORAL ASSET MANAGEMENT Page 2 Third Quarter 2005 had come as the US administration was under pressure to appoint a permanent FDA Commissioner following the Vioxxwithdrawal. [more...]
It is quite clear that not all suits against the pharmaceutical industry are frivolous or without merit, but people listening to what has happened since the Vioxxwithdrawal must be ... [more...]
Pfizer likely to benefit from Vioxxwithdrawal, notes Pharmaprojects . Pfizer is poised to be the company to benefit most from Merck & Co's withdrawal of its COX-2 inhibitor ... [more...]
